https://majorhealthnews.com/press-releases/dominari-reports-q3-2026-resultsMajor Health Newsen2026-11-10T13:08:35.627ZDominari Reports Q3 2026 Results https://majorhealthnews.com/press-releases/city-therapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-cityMajor Health Newsen2026-11-10T12:31:05.750ZCity Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease https://majorhealthnews.com/press-releases/cullinan-therapeutics-provides-corporate-update-and-reports-third-quarter-2026-financialMajor Health Newsen2026-11-10T12:20:22.715ZCullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results https://majorhealthnews.com/press-releases/ovid-therapeutics-reports-business-updates-and-third-quarter-2026-financial-resultsMajor Health Newsen2026-11-10T12:20:05.627ZOvid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results https://majorhealthnews.com/press-releases/black-diamond-therapeutics-announces-positive-updated-silevertinib-phase-2-results-fdaMajor Health Newsen2026-11-10T11:49:31.997ZBlack Diamond Therapeutics Announces Positive Updated Silevertinib Phase 2 Results, FDA Feedback Supporting a Clear Path to Potential Registration in 1L EGFR-NCM NSCLC, and Provides Corporate Update https://majorhealthnews.com/press-releases/lipocine-doses-first-participant-in-bloom-phase-3-study-of-lpcn-1154-for-postpartumMajor Health Newsen2026-11-10T11:31:31.326ZLipocine Doses First Participant in BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression https://majorhealthnews.com/press-releases/rani-therapeutics-reports-third-quarter-2026-financial-results-provides-corporate-updateMajor Health Newsen2026-11-09T22:17:26.177ZRani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update https://majorhealthnews.com/press-releases/illumina-advances-mrd-research-portfolio-with-ultrasensitive-duplex-sequencing-technologyMajor Health Newsen2026-11-09T14:31:03.894ZIllumina advances MRD research portfolio with ultrasensitive duplex sequencing technology https://majorhealthnews.com/press-releases/faeth-reports-positive-preliminary-phase-2-topline-results-from-the-pik-201-trialMajor Health Newsen2026-11-09T12:30:49.671ZFaeth Reports Positive Preliminary Phase 2 Topline Results from the PIK-201 Trial Evaluating PIKTOR in Combination with Paclitaxel in Patients with Advanced Endometrial Cancer https://majorhealthnews.com/press-releases/zura-bio-provides-clinical-update-on-phase-2-tibushield-study-of-tibulizumab-zb-106-inMajor Health Newsen2026-11-09T12:29:43.517ZZura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa https://majorhealthnews.com/press-releases/foghorn-therapeutics-provides-third-quarter-2026-financial-and-corporate-updateMajor Health Newsen2026-11-09T12:28:42.022ZFoghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update https://majorhealthnews.com/press-releases/novocure-provides-regulatory-update-on-us-fda-premarket-approval-application-for-optuneMajor Health Newsen2026-11-09T12:19:55.744ZNovocure Provides Regulatory Update on U.S. FDA Premarket Approval Application for Optune Mya® for Brain Metastases from Non-Small Cell Lung Cancer https://majorhealthnews.com/press-releases/cabaletta-bio-presents-new-rese-cel-phase-12-clinical-data-at-acr-convergence-2026Major Health Newsen2026-11-09T11:28:54.148ZCabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases https://majorhealthnews.com/roundups/food-beverage-and-agriculture-week-of-nov-2-2026Major Health Newsen2026-11-09T13:07:00.000ZKFC deals, restaurant results and growth: the week in food releases https://majorhealthnews.com/roundups/biotech-and-pharma-week-of-nov-2-2026Major Health Newsen2026-11-09T11:28:00.000ZGLP-1 drugs reach rheumatology and telehealth: the week in biotech https://majorhealthnews.com/roundups/health-and-medical-week-of-nov-2-2026Major Health Newsen2026-11-09T11:17:00.000ZQ3 earnings and guidance updates: the week in health releases